|
1
|
MacMahon S, Sharpe N, Gamble G, Hart H,
Scott J, Simes J and White H; LIPID Trial Research Group, : Effects
of lowering average of below-average cholesterol levels on the
progression of carotid atherosclerosis: Results of the LIPID
Atherosclerosis Substudy. Circulation. 97:1784–1790. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hauser ER, Mooser V, Crossman DC, Haines
JL, Jones CH, Winkelmann BR, Schmidt S, Scott WK, Roses AD,
Pericak-Vance MA, et al Design of the Genetics of Early Onset
Cardiovascular Disease study, : Design of the Genetics of Early
Onset Cardiovascular Disease (GENECARD) study. Am Heart J.
145:602–613. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vasilieva EJ, Shpector AV, Raskuragev AB,
Lekochmacher SS and Bespalko IA: Platelet function and plasma lipid
levels in patients with stable and unstable angina pectoris. Am J
Cardiol. 68:959–961. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ogawa H, Yasue H, Misumi I, Masuda T,
Okumura K, Bannai S, Takanashi N and Tsukada Y: Plasma
platelet-derived growth factor levels in coronary circulation in
unstable angina pectoris. Am J Cardiol. 69:453–456. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chakhtoura EY, Shamoon FE, Haft JI,
Obiedzinski GR, Cohen AJ and Watson RM: Comparison of platelet
activation in unstable and stable angina pectoris and correlation
with coronary angiographic findings. Am J Cardiol. 86:835–839.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fitzgerald DJ: Platelet activation in the
pathogenesis of unstable angina: Importance in determining the
response to plasminogen activators. Am J Cardiol. 68:51B–57B. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fitzgerald DJ, Roy L, Catella F and
FitzGerald GA: Platelet activation in unstable coronary disease. N
Engl J Med. 315:983–989. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Frampton J, Buckley MM and Fitton A:
Nicorandil. A review of its pharmacology and therapeutic efficacy
in angina pectoris. Drugs. 44:625–655. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim JH, Jeong MH, Yun KH, Kim KH, Kang DK,
Hong SN, Lim SY, Lee SH, Lee YS, Hong YJ, et al: Myocardial
protective effects of nicorandil during percutaneous coronary
intervention in patients with unstable angina. Circ J. 69:306–310.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Natarajan M: Unstable angina. Clin Evid.
8:225–235. 2002.
|
|
11
|
Xu FH and Wang JM: Clinical observation on
acupuncture combined with medication for intractable angina
pectoris Zhongguo Zhenjiu. 25:89–91. 2005.(In Chinese). PubMed/NCBI
|
|
12
|
Tada M: Unstable angina. Nippon Naika
Gakkai Zasshi. 72:721–726. 1983.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ibuki C: Unstable angina. Nihon Rinsho. 2
(Suppl 5):234–239. 2007.(In Japanese).
|
|
14
|
Waters DD, Walling A, Roy D and Théroux P:
Previous coronary artery bypass grafting as an adverse prognostic
factor in unstable angina pectoris. Am J Cardiol. 58:465–469. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Faxon DP, Detre KM, McCabe CH, Fisher L,
Holmes DR, Cowley MJ, Bourassa MG, Van Raden M and Ryan TJ: Role of
percutaneous transluminal coronary angioplasty in the treatment of
unstable angina. Report from the National Heart, Lung, and Blood
Institute Percutaneous Transluminal Coronary Angioplasty and
Coronary Artery Surgery Study Registries. Am J Cardiol.
53:131C–135C. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lubsen J: Medical management of unstable
angina. What have we learned from the randomized trials?
Circulation. 82 (Suppl):II82–II87. 1990.PubMed/NCBI
|
|
17
|
Walker A, McMurray J, Stewart S, Berger W,
McMahon AD, Dargie H, Fox K, Hillis S, Henderson NJ and Ford I:
Economic evaluation of the impact of nicorandil in angina (IONA)
trial. Heart. 92:619–624. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim SJ, Kim W, Woo JS, Ha SJ, Kang WY,
Hwang SH, Kang DG, Lee SU, Cho SK, Im JS, et al: Effect of
myocardial protection of intracoronary adenosine and nicorandil
injection in patients undergoing non-urgent percutaneous coronary
intervention: A randomized controlled trial. Int J Cardiol.
158:88–92. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Egred M: Nicorandil-associated
ulcerations. Eur J Gastroenterol Hepatol. 19:395–398. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gupta A and Morris G: Major aphthous
ulcers induced by nicorandil. Age Ageing. 29:372–373. 2000.
View Article : Google Scholar : PubMed/NCBI
|
